Current Issue
Early View
Early View Articles
Articles published under Early View have completed peer review and all editorial and production requirements. Early View articles are published online individually before issue assignment and are fully accessible, citable, and indexed upon publication. Once a quarterly issue is finalized, Early View articles are assigned to a specific volume and issue and organized according to editorial structure rather than chronological order of online publication.
Published:
2025-12-16
Review
Welcome to Cancer Biome and Targeted Therapy (CBTT)
Cancer Biome and Targeted Therapy (CBTT) is a peer-reviewed, open-access journal that focuses on multidisciplinary investigations of cancer signaling pathways, biomarkers, diagnostics, and therapeutic targets with an emphasis on the following disciplines:
- Oncology: Molecular and translational cancer research, tumor biology, disease progression, and therapeutic response.
- Immunology: Immune tumor microenvironment and host–tumor interactions.
- Microbiology: Microbial ecosystems, including bacterial, fungal, viral, and parasitic components, and their influence on the tumor niche.
- Biochemistry & Molecular Biology: Molecular cancer mechanisms, signaling, biomarkers, diagnostics, and therapeutic targets.
- Pharmacology and therapeutics: Resistance mechanisms and the development of precision and targeted therapies.
- Molecular Medicine: Molecular and genetic mechanisms underlying cancer initiation, progression, and therapy response.
View our Editorial Team
ISSN: [Pending] | Publisher: GCINC Press, USA
Contact: submissions@cancerbiometherapy.com
Last updated: November 2025
